am 580 has been researched along with tazarotene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charton, J; Deprez, B; Deprez-Poulain, R; Hennuyer, N; Staels, B; Tailleux, A | 1 |
| Carlton, SM; Clark, RB; Du, G; Du, J; Hu, H; Luo, J; Qian, A; Walters, ET; Yang, Q; Yin, S; Yu, W; Zhou, S | 1 |
2 other study(ies) available for am 580 and tazarotene
| Article | Year |
|---|---|
Novel non-carboxylic acid retinoids: 1,2,4-oxadiazol-5-one derivatives.
Topics: Carboxylic Acids; Oxadiazoles; Receptors, Retinoic Acid; Retinoids | 2009 |
Retinoids activate the irritant receptor TRPV1 and produce sensory hypersensitivity.
Topics: Acitretin; Action Potentials; Animals; Benzoates; Bexarotene; Binding Sites; Calcitonin Gene-Related Peptide; Edema; Ganglia, Spinal; HEK293 Cells; Hindlimb; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Molecular; Nicotinic Acids; Nociception; Nociceptors; Receptors, Retinoic Acid; Retinoids; Signal Transduction; Tetrahydronaphthalenes; TRPV Cation Channels | 2013 |